Skip to content

Clinical trials

Completed Phase 2 Carcinoma, Hepatocellular trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Hepatocellular Phase: Phase 2 Status: Completed Clear all

268 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20005
20014
20028
20035
200410
200510
200617
200715
200811
200918
20105
201117
201210
20138
201410
20157
201610
201711
201810
201911
202011
202123
202212
20235
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed268

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)22
Bayer9
M.D. Anderson Cancer Center7
National Taiwan University Hospital6
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest5
Seoul National University Hospital5
Sun Yat-sen University5
Cancer Institute and Hospital, Chinese Academy of Medical Sciences4
Eli Lilly and Company4
Memorial Sloan Kettering Cancer Center4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Hepatocellular268
Liver Neoplasms76
Bile Duct Neoplasms12
Gallbladder Neoplasms12
Neoplasms11
Stomach Neoplasms11
Cholangiocarcinoma8
Neoplasm Metastasis8
Pancreatic Neoplasms7
Colorectal Neoplasms6

Trials

Showing 1 to 25 of 268. Each trial links to its page on Pharma Observatory.

168 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.